Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents - Wikidata - wikimedia - TriplyDB

Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents

Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents

http://www.wikidata.org/entity/Q36787560

about

Substrate Deconstruction and the Nonadditivity of Enzyme Recognition Increasing Chemical Space Coverage by Combining Empirical and Computational Fragment Screens Type II fatty acid biosynthesis is essential for Plasmodium falciparum sporozoite development in the midgut of Anopheles mosquitoes Characterization of the Plasmodium falciparum and P. berghei glycerol 3-phosphate acyltransferase involved in FASII fatty acid utilization in the malaria parasite apicoplast A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.Current therapies and future possibilities for drug development against liver-stage malaria.Antiplasmodial drug targets: a patent review (2000 - 2013).Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 - 2015).Potential of lichen secondary metabolites against Plasmodium liver stage parasites with FAS-II as the potential target.

P2860

Q27683622-24C3625D-50B4-431C-A60A-5A8DCAB7E03F Q27683679-FD994F2D-5864-4C82-8D3C-8F9B52B25C82 Q27973456-57178DD6-FA61-4DF6-A5D3-A2ACB4181F0D Q27974045-74BC0B93-19A5-4129-9B4A-837ED3FC38D0 Q28552140-35941C74-1295-4F74-AFB3-516FFDB1DE47 Q34785012-186DB2DB-A19E-417E-B4AB-ED556F87FFDC Q36729008-B2C4B727-4A7B-4D19-85F3-75B445984E64 Q36951722-1EE966B8-408E-4C96-8913-21D4D19AFD9A Q38632903-00EA93F0-37DC-46CE-8493-7642C3030E35 Q38892242-5D0B0B3A-1D00-4095-AC34-DD1051D91EDB Q42024740-704D0DA1-377B-4902-B0D0-7851BC2C6584

P2860

Novel type II fatty acid biosynthesis (FAS II) inhibitors as multistage antimalarial agents

http://www.wikidata.org/entity/Q36787560

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Novel type II fatty acid biosy ...... multistage antimalarial agents

@en

type

label

Novel type II fatty acid biosy ...... multistage antimalarial agents

@en

prefLabel

Novel type II fatty acid biosy ...... multistage antimalarial agents

@en

P1433

Q36787560-C918F9CF-FA82-49E4-AA5C-DAE1FF62A194

P1476

Q36787560-09A7F28A-D646-4DF3-8E61-6421CD8FC42B

P2093

Q36787560-370BB0B9-C728-4A9A-A07A-05DE2EDF45C7

Q36787560-4B48E413-E22C-45B6-80A8-09076639283D

Q36787560-59B530AE-CBD0-4525-8D4B-F02FC04FDD7C

Q36787560-67302B38-8AD0-4951-B5E2-02BF1C557AFB

Q36787560-84210683-3FD5-4CDD-85EC-63875B88528F

Q36787560-883F5147-F7D7-4739-98E0-D9A1D5E1F727

Q36787560-E1218AA9-A404-41A2-8C88-F4A3E85E62FD

Q36787560-ECD7F8A2-E31C-4779-B434-0E25014284B8

P2860

Q36787560-0B504948-4040-41E5-BBBB-90308EBBCAD7

Q36787560-0F44D627-21B3-47D2-B4D4-55D02C068B6B

Q36787560-13D9204B-FD6B-4C18-ABCA-2AA99B3884B9

Q36787560-17845BF8-2E2A-41F2-AE07-600A11BCCD50

Q36787560-29210CFE-A082-4F63-B143-1F0127120308

Q36787560-3048BF64-A53B-4347-89E3-3024CFA412FC

Q36787560-315E8157-9F49-482A-B50C-68B93C9F74CF

Q36787560-3F05750D-7F5F-4493-ABD9-BD28D910E50A

Q36787560-3FE89B3E-3BB7-4A47-9214-D31FDD65A716

Q36787560-544C05BD-35B3-49B1-AC9D-FE0EB195409D

P304

Q36787560-9D181C34-69A7-4C7A-A655-2A278E47819A

P31

Q36787560-D19F0793-13CB-4A84-80C6-52AD8CEA2531

P356

Q36787560-C7D56F89-1BEA-46F8-BA31-1BB8B4855CB8

P433

Q36787560-4B6EDEC6-FB75-4C25-A549-B09DDB1306A5

P478

Q36787560-FA2DD96A-0074-45A5-A7B5-9029D1FC4F9E

P50

Q36787560-3618C341-1286-4720-B96E-F2F52F592C59

Q36787560-B58E0FBC-A3E2-4C28-BDE6-4F9BD5D2907B

P577

Q36787560-94C6E328-396B-4EBB-85D8-D76D01931B0B

P5875

Q36787560-F6B9F65D-68AB-40E4-B944-7610358DBE96

P698

Q36787560-30EAA084-13CB-4944-821A-9D595CEF59C3

P921

Q36787560-0013AC5E-C0E9-4A95-B575-9CA4C3A2DD03

Q36787560-611634F4-8BA1-43EF-9BF4-E36C68BB7455

P932

Q36787560-A4140DB3-DAB1-4057-A0A0-91D78AB9E6FA

P356

P1433

P1476

Novel type II fatty acid biosy ...... multistage antimalarial agents

@en

P2093

Ann-Kristin Mueller

http://www.w3.org/2001/XMLSchema#string

Florian C Schrader

http://www.w3.org/2001/XMLSchema#string

Gerhard Klebe

http://www.w3.org/2001/XMLSchema#string

Gustavo A Afanador

http://www.w3.org/2001/XMLSchema#string

Hans-Martin Dahse

http://www.w3.org/2001/XMLSchema#string

Julia M Sattler

http://www.w3.org/2001/XMLSchema#string

Martin Schlitzer

http://www.w3.org/2001/XMLSchema#string

Serghei Glinca

http://www.w3.org/2001/XMLSchema#string

P2860

Global malaria mortality between 1980 and 2010: a systematic analysis

Tsc13p is required for fatty acid elongation and localizes to a novel structure at the nuclear-vacuolar interface in Saccharomyces cerevisiae

Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase

Studies ofToxoplasma gondiiandPlasmodium falciparumenoyl acyl carrier protein reductase and implications for the development of antiparasitic agents

X-ray structural analysis of Plasmodium falciparum enoyl acyl carrier protein reductase as a pathway toward the optimization of triclosan antimalarial efficacy

The Fatty Acid Biosynthesis Enzyme FabI Plays a Key Role in the Development of Liver-Stage Malarial Parasites

ZINC--a free database of commercially available compounds for virtual screening

Identification and Development of Novel Inhibitors of Toxoplasma gondii Enoyl Reductase

A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes

Triclosan targets lipid synthesis

P304

442-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201200407

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235363549

http://www.w3.org/2001/XMLSchema#string

P698

23341167

http://www.w3.org/2001/XMLSchema#string

P921

P932

3633473

http://www.w3.org/2001/XMLSchema#string